Classifies LV GLS against the 2025 consensus partition and qualifies the reading by tracking method, vendor/software comparability, tracking quality and loading context.
Classifies each RV linear dimension against the 2025 Table 1 partitions, with the view and timing each measurement requires; indexes the basal diameter when BSA is known.
Classifies TAPSE (cm or mm) against Table 1 after checking cursor alignment, method and the clinical contexts in which TAPSE under- or overestimates RV function.
Reconciles longitudinal (TAPSE, S′, free-wall strain) and global (FAC, 3D RVEF) indices against the Table 1 normal limits and states the limitations of each.
MVA = 220 / PHT. Eligibility-gated: not within 24 h of balloon valvuloplasty, not with moderate/severe AR, not in degenerative (MAC) MS, not for prosthetic valves.
Accepts a traced orifice area and checks that it was measured in a short-axis plane at the leaflet tips in mid-diastole; classifies against the rheumatic MS partition.
Peak gradient 4V² from the CW transpulmonary velocity, proximal correction when the RVOT velocity is not negligible, Table 11 severity, and the PASP = RVSP − PV gradient check.
Compares current mean gradient, EOA and DVI with the designated baseline (stable-condition TTE, 1–3 months after the procedure). Reports whether the Table 6 hemodynamic criterion is met; it does not diagnose structural valve deterioration.
Counts how many of the assessed Doppler parameters fall in the normal, possible-stenosis and significant-stenosis ranges of Table 11. Diagnostic accuracy is best when most parameters agree.
100 × (expiration − inspiration) / expiration from the first beats of each phase; thresholds 30/60% (tamponade) and 25/40% (constriction) by valve and setting.